Fludrocortisone

DRUG INFORMATION

  ADULT
    - The usual dose is 0.1 mg of fludrocortisone acetate tablets daily, although dosage
      ranging from 0.1 mg three times a week to 0.2 mg daily has been employed.
      Source: US FDA label for fludrocortisone (fludrocortisone acetate), section
      'dosage and administration', retrieved 2026-08-29
    - In the event transient hypertension develops as a consequence of therapy, the dose
      should be reduced to 0.05 mg daily.
      Source: US FDA label for fludrocortisone (fludrocortisone acetate), section
      'dosage and administration', retrieved 2026-08-29
    - Fludrocortisone acetate tablets are preferably administered in conjunction with
      cortisone (10 mg to 37.5 mg daily in divided doses) or hydrocortisone (10 mg to 30
      mg daily in divided doses).
      Source: US FDA label for fludrocortisone (fludrocortisone acetate), section
      'dosage and administration', retrieved 2026-08-29

  CHILD
    - Safety and effectiveness in children have not been established. Growth and
      development of infants and children on prolonged corticosteroid therapy should be
      carefully observed.
      Source: US FDA label for fludrocortisone (fludrocortisone acetate), section
      'pediatric use', retrieved 2026-08-29

  RENAL IMPAIRMENT
    - No kidney-impairment dose in this label. Not a statement that none is needed.
      Source: Read and found silent: the US FDA label for fludrocortisone
      (fludrocortisone acetate), retrieved 2026-08-29

  HEPATIC IMPAIRMENT
    - No liver-impairment dose in this label. Not a statement that none is needed.
      Source: Read and found silent: the US FDA label for fludrocortisone
      (fludrocortisone acetate), retrieved 2026-08-29

  PREGNANCY
    - TERATOGENIC EFFECTS Adequate animal reproduction studies have not been conducted
      with fludrocortisone acetate.
      Source: US FDA label for fludrocortisone (fludrocortisone acetate), section
      'pregnancy', retrieved 2026-08-29
    - However, many corticosteroids have been shown to be teratogenic in laboratory
      animals at low doses.
      Source: US FDA label for fludrocortisone (fludrocortisone acetate), section
      'pregnancy', retrieved 2026-08-29
    - Teratogenicity of these agents in man has not been demonstrated.
      Source: US FDA label for fludrocortisone (fludrocortisone acetate), section
      'pregnancy', retrieved 2026-08-29

  BREASTFEEDING   [ CAUTION ]
    The label allows it only when the benefit is judged to outweigh the risk. Read the
      quote below.
    - Corticosteroids are found in the breast milk of lactating women receiving systemic
      therapy with these agents.
      Source: US FDA label for fludrocortisone (fludrocortisone acetate), section
      'nursing mothers', retrieved 2026-08-29
    - Caution should be exercised when fludrocortisone acetate is administered to a
      nursing woman.
      Source: US FDA label for fludrocortisone (fludrocortisone acetate), section
      'nursing mothers', retrieved 2026-08-29